Santen Pharmaceutical Co., Ltd.

TSE:4536 Stock Report

Market Cap: JP¥577.4b

Santen Pharmaceutical Dividends and Buybacks

Dividend criteria checks 5/6

Santen Pharmaceutical is a dividend paying company with a current yield of 2.04% that is well covered by earnings. Next payment date is on 29th November, 2024 with an ex-dividend date of 27th September, 2024.

Key information

2.0%

Dividend yield

5.1%

Buyback Yield

Total Shareholder Yield7.2%
Future Dividend Yield2.4%
Dividend Growth4.6%
Next dividend pay date29 Nov 24
Ex dividend date27 Sep 24
Dividend per shareJP¥34.000
Payout ratio45%

Recent dividend and buyback updates

Recent updates

Santen Pharmaceutical (TSE:4536) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Nov 18
Santen Pharmaceutical (TSE:4536) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Santen Pharmaceutical Co., Ltd. Just Beat EPS By 5.5%: Here's What Analysts Think Will Happen Next

Nov 11
Santen Pharmaceutical Co., Ltd. Just Beat EPS By 5.5%: Here's What Analysts Think Will Happen Next

Santen Pharmaceutical Co., Ltd.'s (TSE:4536) Share Price Could Signal Some Risk

Oct 14
Santen Pharmaceutical Co., Ltd.'s (TSE:4536) Share Price Could Signal Some Risk

Calculating The Intrinsic Value Of Santen Pharmaceutical Co., Ltd. (TSE:4536)

Aug 31
Calculating The Intrinsic Value Of Santen Pharmaceutical Co., Ltd. (TSE:4536)

Santen Pharmaceutical Co., Ltd. Just Recorded A 25% EPS Beat: Here's What Analysts Are Forecasting Next

Aug 08
Santen Pharmaceutical Co., Ltd. Just Recorded A 25% EPS Beat: Here's What Analysts Are Forecasting Next

Unpleasant Surprises Could Be In Store For Santen Pharmaceutical Co., Ltd.'s (TSE:4536) Shares

Jun 25
Unpleasant Surprises Could Be In Store For Santen Pharmaceutical Co., Ltd.'s (TSE:4536) Shares

Santen Pharmaceutical Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models

May 11
Santen Pharmaceutical Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models

Is There An Opportunity With Santen Pharmaceutical Co., Ltd.'s (TSE:4536) 34% Undervaluation?

May 08
Is There An Opportunity With Santen Pharmaceutical Co., Ltd.'s (TSE:4536) 34% Undervaluation?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: 4536's dividends per share have been stable in the past 10 years.

Growing Dividend: 4536's dividend payments have increased over the past 10 years.


Dividend Yield vs Market

Santen Pharmaceutical Dividend Yield vs Market
How does 4536 dividend yield compare to the market?
SegmentDividend Yield
Company (4536)2.0%
Market Bottom 25% (JP)1.8%
Market Top 25% (JP)3.8%
Industry Average (Pharmaceuticals)2.4%
Analyst forecast (4536) (up to 3 years)2.4%

Notable Dividend: 4536's dividend (2.04%) is higher than the bottom 25% of dividend payers in the JP market (1.83%).

High Dividend: 4536's dividend (2.04%) is low compared to the top 25% of dividend payers in the JP market (3.8%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (45%), 4536's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (18.6%), 4536's dividend payments are well covered by cash flows.


Discover strong dividend paying companies